Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer

被引：0
|
作者：
Olufemi Olayide Ojewuyi
Stephen Odunayo Ikuerowo
Emmanuel Ajibola Jeje
Oladipo Adeboluji Adewole
Abimbola Ayodeji Abolarinwa
Olufunmilade Akinfolarin Omisanjo
机构：
[1] Ladoke Akintola University of Technology (LAUTECH) Teaching Hospital,Urology Unit, Department of Surgery
[2] Lagos State University College of Medicine and Lagos State University Teaching Hospital,Urology Division, Department of Surgery
[3] Laos State University College of Medicine and Lagos State University Teaching Hospital,Department of Orthopaedics and Trauma
[4] College of Medicine and University of Lagos and Lagos University Teaching Hospital,Urology Unit, Department of Surgery
来源：
African Journal of Urology | 2020年 / 26卷
关键词：
Prostate cancer; Androgen deprivation therapy; Benign prostatic hyperplasia; Bone mineral density;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    R B Egerdie
    F Saad
    M R Smith
    T L J Tammela
    J Heracek
    P Sieber
    C Ke
    B Leder
    R Dansey
    C Goessl
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 308 - 312
  • [22] Toremifene citrate increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
    Smith, M. R.
    Chu, F.
    Forrest, J.
    Malkowicz, S. B.
    Price, D.
    Sieber, P.
    Barnette, K. G.
    Segal, S.
    Steiner, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 229S - 229S
  • [23] Management of decreased bone mineral density (BMD) in men starting androgen deprivation therapy (ADT) for prostate cancer
    Panju, A. H.
    Breunis, H.
    Cheung, A. M.
    Duff-Canning, S.
    Fleshner, N. E.
    Krahn, M.
    Naglie, G.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] A RESPONDER ANALYSIS OF THE EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
    Egerdie, Blair
    Smith, Matthew R.
    Tammela, Teuvo L. J.
    Saad, Fred
    Ke, Chunlei
    Goessl, Carsten
    Dansey, Roger
    JOURNAL OF UROLOGY, 2009, 181 (04): : 611 - 611
  • [25] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Egerdie, R. B.
    Saad, F.
    Smith, M. R.
    Tammela, T. L. J.
    Heracek, J.
    Sieber, P.
    Ke, C.
    Leder, B.
    Dansey, R.
    Goessl, C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (03) : 308 - 312
  • [26] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    S Yaturu
    S DjeDjos
    G Alferos
    C Deprisco
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 35 - 38
  • [27] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    Yaturu, S
    DjeDjos, S
    Alferos, G
    Deprisco, C
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 35 - 38
  • [28] Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density.
    Alferos, MG
    Yaturu, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S243 - S243
  • [29] Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy
    Bernat, MM
    Pasini, J
    Marekovic, Z
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 589 - 591
  • [30] Bone mineral density testing after initiation of androgen deprivation therapy for prostate cancer
    Hu, Jason
    Dragomir, Alice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 521 - 521
12345